Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

<p><strong>Background.</strong> The progression and geographical distribution of SARS coronavirus 2 (SARS-CoV-2) infection in the UK and elsewhere is unknown because typically only symptomatic individuals are diagnosed. We performed a serological study of blood donors in Scotland b...

Full description

Bibliographic Details
Main Authors: Thompson, CP, Grayson, N, Paton, R, Bolton, JS, Lourenco, J, Penman, B, Lee, LN, Odon, V, Mongkolsapaya, J, Chinnakannan, S, Dejnirattisai, W, Edmans, M, Fyfe, A, Imlach, C, Kooblall, K, Lim, N, Liu, C, Lopez-Camacho, C, McInally, C-A, McNaughton, AL, Ramamurthy, N, Ratcliff, J, Supasa, P, Wang, B, Mentzer, AJ, Turner, M, Sampson, O, Semple, C, Baillie, JK, ISARIC4C Investigators, Harvala, H, Screaton, G, Temperton, N, Klenerman, P, Jarvis, L, Gupta, S, Simmonds, P
Format: Journal article
Language:English
Published: European Centre for Disease Prevention and Control 2020
_version_ 1797096340778385408
author Thompson, CP
Grayson, N
Paton, R
Bolton, JS
Lourenco, J
Penman, B
Lee, LN
Odon, V
Mongkolsapaya, J
Chinnakannan, S
Dejnirattisai, W
Edmans, M
Fyfe, A
Imlach, C
Kooblall, K
Lim, N
Liu, C
Lopez-Camacho, C
McInally, C-A
McNaughton, AL
Ramamurthy, N
Ratcliff, J
Supasa, P
Wang, B
Mentzer, AJ
Turner, M
Sampson, O
Semple, C
Baillie, JK
ISARIC4C Investigators
Harvala, H
Screaton, G
Temperton, N
Klenerman, P
Jarvis, L
Gupta, S
Simmonds, P
author_facet Thompson, CP
Grayson, N
Paton, R
Bolton, JS
Lourenco, J
Penman, B
Lee, LN
Odon, V
Mongkolsapaya, J
Chinnakannan, S
Dejnirattisai, W
Edmans, M
Fyfe, A
Imlach, C
Kooblall, K
Lim, N
Liu, C
Lopez-Camacho, C
McInally, C-A
McNaughton, AL
Ramamurthy, N
Ratcliff, J
Supasa, P
Wang, B
Mentzer, AJ
Turner, M
Sampson, O
Semple, C
Baillie, JK
ISARIC4C Investigators
Harvala, H
Screaton, G
Temperton, N
Klenerman, P
Jarvis, L
Gupta, S
Simmonds, P
author_sort Thompson, CP
collection OXFORD
description <p><strong>Background.</strong> The progression and geographical distribution of SARS coronavirus 2 (SARS-CoV-2) infection in the UK and elsewhere is unknown because typically only symptomatic individuals are diagnosed. We performed a serological study of blood donors in Scotland between the 17th of March and the 18th of May to detect neutralising antibodies to SARS-CoV-2 as a marker of past infection and epidemic progression. </p> <p><strong>Aim.</strong> To determine if sera from blood bank donors can be used to track the emergence and progression of the SARS-CoV-2 epidemic. </p> <p><strong>Methods.</strong> A pseudotyped SARS-CoV-2 virus microneutralisation assay was used to detect neutralising antibodies to SARS-CoV-2. The study group comprised samples from 3,500 blood donors collected in Scotland between the 17th of March and 19th of May, 2020. Controls were collected from 100 donors in Scotland during 2019. </p> <p><strong>Results.</strong> All samples collected on the 17th March, 2020 (n=500) were negative in the pseudotyped SARS-CoV-2 virus microneutralisation assay. Neutralising antibodies were detected in 6/500 donors from the 23th-26th of March. The number of samples containing neutralising antibodies did not significantly rise after the 5th-6th April until the end of the study on the 18th of May. We find that infections are concentrated in certain postcodes indicating that outbreaks of infection are extremely localised. In contrast, other areas remain comparatively untouched by the epidemic. </p> <p><strong>Conclusion.</strong> These data indicate that sero-surveys of blood banks can serve as a useful tool for tracking the emergence and progression of an epidemic like the current SARS-CoV-2 outbreak.</p>
first_indexed 2024-03-07T04:40:25Z
format Journal article
id oxford-uuid:d16f0f99-2614-4e43-a6cc-60e722cdbbe1
institution University of Oxford
language English
last_indexed 2024-03-07T04:40:25Z
publishDate 2020
publisher European Centre for Disease Prevention and Control
record_format dspace
spelling oxford-uuid:d16f0f99-2614-4e43-a6cc-60e722cdbbe12022-03-27T07:57:09ZDetection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d16f0f99-2614-4e43-a6cc-60e722cdbbe1EnglishSymplectic ElementsEuropean Centre for Disease Prevention and Control2020Thompson, CPGrayson, NPaton, RBolton, JSLourenco, JPenman, BLee, LNOdon, VMongkolsapaya, JChinnakannan, SDejnirattisai, WEdmans, MFyfe, AImlach, CKooblall, KLim, NLiu, CLopez-Camacho, CMcInally, C-AMcNaughton, ALRamamurthy, NRatcliff, JSupasa, PWang, BMentzer, AJTurner, MSampson, OSemple, CBaillie, JKISARIC4C InvestigatorsHarvala, HScreaton, GTemperton, NKlenerman, PJarvis, LGupta, SSimmonds, P<p><strong>Background.</strong> The progression and geographical distribution of SARS coronavirus 2 (SARS-CoV-2) infection in the UK and elsewhere is unknown because typically only symptomatic individuals are diagnosed. We performed a serological study of blood donors in Scotland between the 17th of March and the 18th of May to detect neutralising antibodies to SARS-CoV-2 as a marker of past infection and epidemic progression. </p> <p><strong>Aim.</strong> To determine if sera from blood bank donors can be used to track the emergence and progression of the SARS-CoV-2 epidemic. </p> <p><strong>Methods.</strong> A pseudotyped SARS-CoV-2 virus microneutralisation assay was used to detect neutralising antibodies to SARS-CoV-2. The study group comprised samples from 3,500 blood donors collected in Scotland between the 17th of March and 19th of May, 2020. Controls were collected from 100 donors in Scotland during 2019. </p> <p><strong>Results.</strong> All samples collected on the 17th March, 2020 (n=500) were negative in the pseudotyped SARS-CoV-2 virus microneutralisation assay. Neutralising antibodies were detected in 6/500 donors from the 23th-26th of March. The number of samples containing neutralising antibodies did not significantly rise after the 5th-6th April until the end of the study on the 18th of May. We find that infections are concentrated in certain postcodes indicating that outbreaks of infection are extremely localised. In contrast, other areas remain comparatively untouched by the epidemic. </p> <p><strong>Conclusion.</strong> These data indicate that sero-surveys of blood banks can serve as a useful tool for tracking the emergence and progression of an epidemic like the current SARS-CoV-2 outbreak.</p>
spellingShingle Thompson, CP
Grayson, N
Paton, R
Bolton, JS
Lourenco, J
Penman, B
Lee, LN
Odon, V
Mongkolsapaya, J
Chinnakannan, S
Dejnirattisai, W
Edmans, M
Fyfe, A
Imlach, C
Kooblall, K
Lim, N
Liu, C
Lopez-Camacho, C
McInally, C-A
McNaughton, AL
Ramamurthy, N
Ratcliff, J
Supasa, P
Wang, B
Mentzer, AJ
Turner, M
Sampson, O
Semple, C
Baillie, JK
ISARIC4C Investigators
Harvala, H
Screaton, G
Temperton, N
Klenerman, P
Jarvis, L
Gupta, S
Simmonds, P
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
title Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
title_full Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
title_fullStr Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
title_full_unstemmed Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
title_short Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
title_sort detection of neutralising antibodies to sars cov 2 to determine population exposure in scottish blood donors between march and may 2020
work_keys_str_mv AT thompsoncp detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT graysonn detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT patonr detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT boltonjs detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT lourencoj detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT penmanb detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT leeln detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT odonv detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT mongkolsapayaj detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT chinnakannans detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT dejnirattisaiw detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT edmansm detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT fyfea detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT imlachc detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT kooblallk detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT limn detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT liuc detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT lopezcamachoc detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT mcinallyca detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT mcnaughtonal detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT ramamurthyn detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT ratcliffj detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT supasap detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT wangb detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT mentzeraj detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT turnerm detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT sampsono detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT semplec detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT bailliejk detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT isaric4cinvestigators detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT harvalah detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT screatong detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT tempertonn detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT klenermanp detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT jarvisl detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT guptas detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020
AT simmondsp detectionofneutralisingantibodiestosarscov2todeterminepopulationexposureinscottishblooddonorsbetweenmarchandmay2020